Gamida Cell to Present at the 31st Annual Piper Jaffray Healthcare Conference

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced that Julian Adams, Ph.D., the company’s chief executive officer, will participate in a “fireside chat” at the 31st Annual Piper Jaffray Healthcare Conference on Thursday, December 5, 2019, at 1:00 p.m. ET in New York City.

A live webcast of the presentation will be available on the Investors section of the Gamida Cell website, www.gamida-cell.com, and will be available for 30 days following the event.

About Gamida Cell Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. For additional information, please visit www.gamida-cell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191121005114/en/

Jaren Irene Madden jaren@gamida-cell.com 617-286-6264

Krystle Gibbs (media) krystle@tenbridgecommunications.com 508-479-6358

Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Mar 2024 to Apr 2024